presentazione di powerpoint · today tomorrow the neuromodulation market revenue data from...

25

Upload: others

Post on 12-Mar-2021

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues
Page 2: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Wiringless Implantable Stretchable Electronics

Page 3: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

WISE vison

Fast market entry with Cortical Grids.

Market Breakthrough with Foldable SCS paddles.

We will revolutionize

leads manufacturing

First to produce Neuro-leads: highly conformable, completely stretchable, minimally invasive.

Page 4: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

The Neuro-leads Scenario

Neuromodulation therapies:

Chronic pain (SCS)

Parkinson’s disease

Dystonia

Epilepsy

Depression

and many others …

Neuromonitoring Electrodes(iEEG)

NeurostimulationLeads (SCS, DBS)

Acute application:

Intra-Operative Neuro-Monitoring (IONM)

Identification of epileptogenic zones

Page 5: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Today Tomorrow

The Neuromodulation Market

Revenue data from Corporate Annual Reports (2005-2016)

• Neuromodulation Rev. (2016): $3.4B

• 15% of Revenues come from Leads

Constant growth by

~10%

The limits of current leads technology

are major roadblock on the way to

new therapies.

Page 6: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Current Market Problems

!

Neuromodulation LeadsNeuromonitoring Electrodes

INVASIVE

MIGRATION

BREAKAGE

LIMITED COMPLEXITY

HIGH PROD. COSTS

Bulky

Poorly conformable

Poorly stretchable

Low resolution

Hand assembled

Page 7: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Arbitrarily thin

Highly conformable

Highly stretchable

High resolution

Automation

LOW INVASIVITY

NO MIGRATION

NO BREAKAGE

UNLIMITED COMPLEXITY

LOWER PROD. COSTS

Neuromonitoring Electrodes Neuromodulation Leads

The WISE Solution: Next-generation leads

Page 8: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Neuro2World Connection

Soft tissue Hard electronic devices

Mechanical

mismatch

Hard metal leads

Conductiveelastomer

Device

Young’s Modulus (Pa)

Page 9: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

The WISE technology

Stretchable

polymer

Supersonic

cluster beam

source

Conductive

nanoparticles (Pt, Ir)

Unrivaled stretchability

Arbitrarily soft & thin substrate

Biocompatible (ISO 10993-1:2009 Tests)

Easy manufacturing Conductive stretchable

nanocomposite

PCT/EP2011/054903

Page 10: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Easy Manufacturing

Arbitrarily soft & thin substrate (cold technology)

Page 11: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

No Engineering Limitations

Any shape

Any size (from m to cm)

200 m4 mm

Any polymer

Polyurethanes

PMMAsSilicones

Page 12: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Robust Interconnection to standard electronics

wire

Robust interconnection

High risk of breakage

Need for wiring

Patent: PCT Nr. PCT/IB2017/053056

Page 13: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Cortical Grids: Overview

Intra-operative or Acute: max 29 days

Monitoring/mapping the cortical surface during brain surgery (IOM) or before the surgical treatment of Epilepsy (ECoG)

Single-use

Cortical grids are used for the recording, monitoring and stimulation of electrical signal on the surface level of the brain.

Page 14: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

WISE’s Cortical Grids

Page 15: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Cortical Grids: WISE vs. Commercial

COMMERCIAL

Page 16: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Neuromodulation Leads: SCS Paddles

The first “Foldable SCS Paddle lead”

An SCS lead with all the advantages of a

Paddle lead

implanted byminimally invasive surgery

as a Percutaneous lead

Page 17: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

SCS leads: Paddle vs. Percutaneous

PercutaneousPaddles

Two types of Leads are used for SCS:

Better stim. (directional)

Invasive/Costly insertion

Precise stim. spot (grid)

Complex removal

Worse stim. (non directional)

Easy/Cheap insertion

Less Precise stim. spot

Easier removal

Surgically placed Implanted through a needle

WISE’s Foldable SCS Paddle lead

This will change the

SCS paradigm

Requires WISE’s technology

WISE’s Foldable SCS Paddle lead

Page 18: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

WISE’s Foldable SCS Paddle lead

Foldable in less than 4 mm

Product in development

Page 19: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Patenting & kickoff

WISE’s Roadmap

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

Angel round

Agite!2011

Page 20: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Technology Consolidation

Patenting & kickoff

WISE’s Roadmap

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

Angel round

Seed round

2012

250,000€ Investment

Page 21: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Prototyping & Animal testing

Technology Consolidation

Patenting & kickoff

WISE’s Roadmap

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

Angel round

Seed round

Seed+ round

€1M

2013

Page 22: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Prototyping & Animal testing

Technology Consolidation

Patenting & kickoff

WISE’s Roadmap

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

Angel round

Seed round

VC series A

€3M

Seed+ round

€1M

2015

CE mark / Market

Cortical Grids

Engineering,

Regulatory &

Clinical Trials

Page 23: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

Prototyping & Animal testing

Technology Consolidation

Patenting & kickoff

Foldable Paddle

Engineering,

Preclinical &

Clinical Trials

CE mark / Market

WISE’s Roadmap

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

Angel round

Seed round

VC series B

€6.5M

VC series A

€3M

Seed+ round

€1M

CE mark / Market

Cortical Grids

Engineering,

Regulatory &

Clinical Trials

Tot. €11M

Page 24: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

WISE Factory

• 1000 m2 facility• Offices, Labs and Production• 120 m2 of ISO 7 cleanrooms

Production

R&D

Offices

120 m2 ISO7 Cleanroom

R&D Lab

Production Lab

Offices

Page 25: Presentazione di PowerPoint · Today Tomorrow The Neuromodulation Market Revenue data from Corporate Annual Reports (2005-2016) •Neuromodulation Rev. (2016): $3.4B •15% of Revenues

WISE’s Team